title: Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients.
authors.forename: E
authors.initials: E
authors.lastname: Hatch
authors.forename: H
authors.initials: H
authors.lastname: Wynne
authors.forename: P
authors.initials: P
authors.lastname: Avery
authors.forename: M
authors.initials: M
authors.lastname: Wadelius
authors.forename: F
authors.initials: F
authors.lastname: Kamali
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000235:genetics; D010597:Pharmacogenetics / Q000379:methods*; D011110:Polymorphism, Genetic; D013548:Sweden; D006113:United Kingdom; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; C400322:cytochrome P-450 CYP2C subfamily; D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D064417:Vitamin K Epoxide Reductases